Skip to main content
. 2018 Jul 24;2(14):1792–1798. doi: 10.1182/bloodadvances.2018021345

Table 2.

Base-case sensitivity analysis

Variables Prophylaxis Gene therapy Difference
Total cost $1 693 630 $1 022 249 $671 381
Effectiveness, QALYs 6.62 8.33 −1.71
Incremental cost-effectiveness ratio, $/QALY Dominated Dominant

Cost and QALYs are discounted at 3% per year.